Exor N.V.
EXO.XAMS
Exor N.V. is a diversified public holding company controlled by the Italian Agnelli family through Giovanni Agnelli B.V., which holds 55.07% of shares and 86% of voting rights due to a loyalty voting structure. Incorporated in the Netherlands, it traces its origins to 1927 as Istituto Finanziario Industriale, founded by Senator Giovanni Agnelli to consolidate investments, primarily in FIAT, now evolved into a century-long portfolio across multiple sectors. Its key holdings include major stakes in automotive giants Stellantis and Ferrari, agricultural and construction equipment maker CNH Industrial, health technology firm Philips (15%, with potential to 20%), data analytics provider Clarivate (10.1%), the iconic magazine The Economist, football club Juventus FC, and media group GEDI Gruppo Editoriale. Exor N.V. also nurtures innovation through Exor Ventures, investing in over 100 startups in mobility, fintech, and healthcare; Lingotto, its alternative investment manager launched in 2023; and recent ventures like VENTO for Italian seed funding and stakes in healthcare (Lifenet, Institut Mérieux) and luxury (Christian Louboutin). Led by CEO John Elkann, Exor N.V. plays a pivotal role in global markets by fostering long-term value in automotive, industrial, media, and technology sectors, recently divesting Iveco Group in 2025.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
-€3.59B
▼ -123.5% YoY
Net Income (TTM)
-€3.79B
▼ -125.9% YoY
Op. Margin
–
ROIC
–
Cash Flow & Balance Sheet
FCF (TTM)
€2.86B
▲ +5991.5% YoY
Op. Cash Flow (TTM)
€2.86B
▲ +5991.5% YoY
Net Debt
€2.25B
Cash & Equiv.
€1.41B
5Y CAGR: -25.4%
Continue Research
Peers
Asset Management · Pick stocks to compare with EXO.XAMS
Held by ETFs
EXO.XAMS is in 58 US ETFs. The largest of them, with EXO.XAMS's weight in each:
Vanguard FTSE Developed Markets ETFVEA0.02%of the fund
iShares Core MSCI EAFE ETFIEFA0.03%of the fund
iShares MSCI EAFE ETFEFA0.03%of the fund
Schwab International Equity ETFSCHF0.02%of the fund
State Street SPDR Portfolio Developed World ex-US ETFSPDW0.02%of the fund
Vanguard FTSE Europe ETFVGK0.04%of the fund
Exor (EXO.XAMS) in three numbers
Questions about Exor
Is Exor (EXO.XAMS) overvalued?
Exor trades at 5.27 times free cash flow. Intrinsiqq's fair value calculator has no opening value for EXO.XAMS, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.
Is Exor a high-quality business?
Exor scores 42 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 4 checks computed from company filings. Its best check is share count change at -10.8%, and its weakest is net debt at $2.25B. The Quality tab shows every check against its target.
Does Exor (EXO.XAMS) pay a dividend, and how much?
Yes. Exor (EXO.XAMS) pays a dividend: €0.49 per share over the last twelve months, a dividend yield of 0.70% at the latest close. Its dividend per share has grown at 3.2% a year over the last 2 years. The Dividends tab has the full payment history and the safety score.
Source: company filings. Price: last close 13 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing EXO.XAMS
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.